USD 23.1
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 212.78 Million EUR | 13.88% |
2022 | 228.25 Million EUR | 8.45% |
2021 | 213.98 Million EUR | 12.3% |
2020 | 192.49 Million EUR | 11.55% |
2019 | 176.28 Million EUR | -3.69% |
2018 | 185.11 Million EUR | 66.86% |
2017 | 111.43 Million EUR | -12.21% |
2016 | 126.73 Million EUR | 6.26% |
2015 | 116.83 Million EUR | 18.71% |
2014 | 101.78 Million EUR | 12.46% |
2013 | 89.48 Million EUR | -13.54% |
2012 | 103.44 Million EUR | 29.91% |
2011 | 73.34 Million EUR | 10.49% |
2010 | 70.51 Million EUR | 14.28% |
2009 | 61.7 Million EUR | 6.94% |
2008 | 51.88 Million EUR | 1456.57% |
2007 | 57.82 Million EUR | -88.2% |
2006 | 31.4 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 55.17 Million EUR | -7.31% |
2024 Q1 | 61.07 Million EUR | -11.04% |
2023 Q4 | 67.99 Million EUR | 13.56% |
2023 Q1 | 55.64 Million EUR | -8.05% |
2023 Q2 | 77.77 Million EUR | 39.77% |
2023 FY | - EUR | 13.88% |
2023 Q3 | 59.87 Million EUR | -23.02% |
2022 Q1 | 55.79 Million EUR | 6.59% |
2022 Q4 | 60.52 Million EUR | -19.61% |
2022 FY | - EUR | 8.45% |
2022 Q3 | 75.28 Million EUR | 62.46% |
2022 Q2 | 46.33 Million EUR | -16.95% |
2021 Q2 | 51.68 Million EUR | 15.18% |
2021 Q4 | 52.34 Million EUR | -25.85% |
2021 Q3 | 70.59 Million EUR | 36.58% |
2021 FY | - EUR | 12.3% |
2021 Q1 | 44.87 Million EUR | 7.43% |
2020 Q4 | 41.77 Million EUR | -39.8% |
2020 FY | - EUR | 11.55% |
2020 Q3 | 69.38 Million EUR | 65.19% |
2020 Q2 | 42 Million EUR | 2.33% |
2020 Q1 | 41.04 Million EUR | -13.07% |
2019 FY | - EUR | -3.69% |
2019 Q1 | 50.32 Million EUR | 5.53% |
2019 Q2 | 37.64 Million EUR | -25.19% |
2019 Q3 | 44.48 Million EUR | 18.17% |
2019 Q4 | 47.22 Million EUR | 6.16% |
2018 Q3 | 37.26 Million EUR | -33.16% |
2018 Q4 | 47.68 Million EUR | 27.95% |
2018 FY | - EUR | 66.86% |
2018 Q2 | 55.75 Million EUR | 42.74% |
2018 Q1 | 39.05 Million EUR | 112.3% |
2017 Q2 | 34.3 Million EUR | 6.48% |
2017 FY | - EUR | -12.21% |
2017 Q1 | 32.22 Million EUR | -8.02% |
2017 Q4 | 18.39 Million EUR | -34.84% |
2017 Q3 | 28.23 Million EUR | -17.71% |
2016 Q2 | 31.54 Million EUR | -2.12% |
2016 FY | - EUR | 6.26% |
2016 Q1 | 32.23 Million EUR | 26.68% |
2016 Q3 | 28.12 Million EUR | -10.87% |
2016 Q4 | 35.03 Million EUR | 24.57% |
2015 Q1 | 43.29 Million EUR | 91.71% |
2015 FY | - EUR | 18.71% |
2015 Q3 | 22.85 Million EUR | -23.21% |
2015 Q2 | 29.75 Million EUR | -31.27% |
2015 Q4 | 25.44 Million EUR | 11.35% |
2014 Q3 | 33.63 Million EUR | 40.79% |
2014 Q4 | 22.58 Million EUR | -32.85% |
2014 FY | - EUR | 12.46% |
2014 Q1 | 22.46 Million EUR | 23.48% |
2014 Q2 | 23.89 Million EUR | 6.33% |
2013 Q3 | 25.25 Million EUR | 39.86% |
2013 Q4 | 18.19 Million EUR | -27.96% |
2013 FY | - EUR | -13.54% |
2013 Q1 | 28.65 Million EUR | 30.41% |
2013 Q2 | 18.05 Million EUR | -36.98% |
2012 Q1 | 26.72 Million EUR | -8.67% |
2012 Q3 | 23.56 Million EUR | -24.45% |
2012 Q4 | 21.97 Million EUR | -6.75% |
2012 FY | - EUR | 29.91% |
2012 Q2 | 31.19 Million EUR | 16.72% |
2011 Q3 | 23.4 Million EUR | 120.73% |
2011 Q2 | 10.6 Million EUR | -27.66% |
2011 Q1 | 14.65 Million EUR | -35.0% |
2011 FY | - EUR | 10.49% |
2011 Q4 | 29.25 Million EUR | 25.03% |
2010 Q3 | 18.21 Million EUR | 9.88% |
2010 Q2 | 16.57 Million EUR | 25.66% |
2010 FY | - EUR | 14.28% |
2010 Q1 | 13.19 Million EUR | -29.6% |
2010 Q4 | 22.54 Million EUR | 23.79% |
2009 FY | - EUR | 6.94% |
2009 Q1 | 12.72 Million EUR | 0.0% |
2009 Q3 | 16.53 Million EUR | 20.58% |
2009 Q4 | 18.73 Million EUR | 13.34% |
2009 Q2 | 13.71 Million EUR | 7.71% |
2008 FY | - EUR | 1456.57% |
2007 FY | - EUR | -88.2% |
2006 FY | - EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Achiko AG | -8.32 Million USD | 2655.804% |
Accelera Innovations, Inc | - USD | -Infinity% |
Aspyra Inc. | -2.84 Million USD | 7575.807% |
Cannabis Sativa, Inc. | -1.11 Million USD | 19192.122% |
CompuMed, Inc. | 690.19 Thousand USD | -30730.306% |
CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 0.0% |
Cogstate Limited | 9.89 Million USD | -2051.268% |
CareView Communications, Inc. | -210.04 Thousand USD | 101407.84% |
Craneware plc | 54.26 Million USD | -292.164% |
Caduceus Software Systems Corp. | -12.29 Million USD | 1831.033% |
Certive Solutions Inc. | -704.66 Thousand USD | 30297.087% |
Drug Free Solution, Inc. | -1.39 Million USD | 15354.418% |
DATATRAK International, Inc. | 2.72 Million USD | -7698.563% |
Strainsforpains, Inc. | -65.61 Thousand USD | 324422.512% |
Healixa Inc. | -6.32 Million USD | 3466.711% |
Easy Technologies Inc. | - USD | -Infinity% |
eWellness Healthcare Corporation | - USD | -Infinity% |
Founders Bay Holdings | 10.16 Million USD | -1992.595% |
Health Discovery Corporation | - USD | -Infinity% |
Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | 50110.341% |
H-Source Holdings Ltd. | - USD | -Infinity% |
InterCare DX, Inc. | - USD | -Infinity% |
iCoreConnect Inc. | -11.87 Million USD | 1891.237% |
IQ-AI Limited | -370.35 Thousand USD | 57555.455% |
Cannabiz Mobile, Inc. | -750.00 USD | 28371833.333% |
Mednow Inc. | -28.12 Million USD | 856.621% |
Galileo Life Sciences, Inc. | -270.72 Thousand USD | 78699.897% |
MediXall Group, Inc. | -6.52 Million USD | 3361.828% |
Mitesco, Inc. | -11.96 Million USD | 1878.662% |
MobileSmith, Inc. | -13.83 Million USD | 1637.767% |
NantHealth, Inc. | -38.53 Million USD | 652.208% |
Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 12631.684% |
OneLife Technologies Corp. | - USD | -Infinity% |
ORHub, Inc. | -12.08 Million USD | 1860.525% |
Patient Access Solutions, Inc. | -12.09 Million USD | 1858.813% |
Pharma-Bio Serv, Inc. | 1.31 Million USD | -16121.911% |
PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | -284642.406% |
Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | 1746554.366% |
Renalytix Plc | -28.52 Million USD | 846.075% |
Revium Recovery Inc. | -678 Thousand USD | 31484.661% |
RYAH Group, Inc. | - USD | -Infinity% |
Carepay Inc. | -369.00 USD | 57666224.661% |
Vaso Corporation | 4.19 Million USD | -4972.42% |
Vynleads, Inc. | -235.72 Thousand USD | 90369.211% |